You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 107 No. 9, September 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Circumscribed choroidal hemangiomas

R. Anand, J. J. Augsburger and J. A. Shields
Wills Eye Hospital, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107.

We report observations of 71 patients with circumscribed choroidal hemangiomas. Each of these patients had a unilateral choroidal tumor with characteristic ophthalmoscopic, fluorescein angiographic, and ultrasonographic features. The affected patients ranged in age from 9 to 86 years when diagnosed. Sixty-four (90%) of the 71 patients were followed up by use after their initial diagnostic examination. The median follow-up was 45.5 months (range, 6 weeks to 12 years). Forty-two of the 64 patients were treated with scatter photocoagulation to the tumor surface on one or more occasions for vision-impairing or vision-threatening nonrhegmatogenous retinal detachment. The subretinal fluid resolved following photocoagulation in all of these eyes, and the vision stabilized in 34 patients (53%). However, the visual acuity at the most recent follow-up was less than 6/15 in 46 (72%) of the 64 affected eyes. Scatter photocoagulation, as employed in this group of patients, frequently results in retinal reattachment and temporary visual improvement, but many patients have permanently decreased vision in the affected eye, particularly when the tumor or the retinal detachment affects the foveal area. One third of the patients with 6/60 or better visual acuity at presentation are estimated to deteriorate to less than 6/60 visual acuity within 10 years.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vascular Lesions of the Orbit: More than Meets the Eye
Smoker et al.
RadioGraphics 2008;28:185-204.
ABSTRACT | FULL TEXT  

Palladium 103 (103Pd) Plaque Radiation Therapy for Circumscribed Choroidal Hemangioma With Retinal Detachment
Aizman et al.
Arch Ophthalmol 2004;122:1652-1656.
ABSTRACT | FULL TEXT  

Photodynamic therapy of circumscribed choroidal haemangioma
Singh et al.
Br. J. Ophthalmol. 2004;88:1414-1418.
ABSTRACT | FULL TEXT  

Low-Dose Proton Beam Therapy for Circumscribed Choroidal Hemangiomas
Frau et al.
Arch Ophthalmol 2004;122:1471-1475.
ABSTRACT | FULL TEXT  

Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma
Jurklies et al.
Br. J. Ophthalmol. 2003;87:84-89.
ABSTRACT | FULL TEXT  

Choroidal Hemangioma Treated With Photodynamic Therapy Using Verteporfin
Madreperla
Arch Ophthalmol 2001;119:1606-1610.
ABSTRACT | FULL TEXT  

Circumscribed Choroidal Hemangioma Managed by Transpupillary Thermotherapy
Othmane et al.
Arch Ophthalmol 1999;117:136-137.
FULL TEXT  

Radiotherapy for ocular angiomas
PLOWMAN and HUNGERFORD
Br. J. Ophthalmol. 1997;81:258-259.
FULL TEXT  

Long term results after low dose ocular irradiation for choroidal haemangiomas
Schilling et al.
Br. J. Ophthalmol. 1997;81:267-273.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.